Agenda / Schedule

The Global Life Sciences Hub

Schedule
Research & Discovery BD&L & Investment Clinical Development Medical & Regulatory Manufacturing & Supply Market Access & Comm. Digital Health & AI
Time Stream 1Stream 2Stream 3Stream 4Stream 5Stream 6Stream 7
07:30–08:30 Conference Registration — Registration, Badge Collection & Morning Coffee
08:30–08:40 Chairman's Address  |  Dimitri F. Dimitriou — Chairman, U.S Biotech Day  |  Discovery Hall
08:45–09:15 Panel Discussion Target Identification in 2026: Human Genetics & Causal Biology Research & Discovery Hall 1 Panel Discussion Collaborate or Collapse – Partnerships as the Lifeline of Biotech BD&L & Investment Hall 2 Keynote From Reactive to Predictive: Modernizing Regulatory Affairs Medical & Regulatory Hall 4
08:55–09:25 Panel Discussion Designing High-Quality Clinical Trials: Protocol & Data Integrity Clinical Development Hall 3 Keynote Keynote Presentation 1 Manufacturing & Supply Hall 5 Panel Discussion Real-World Data, Digital Biomarkers & Predictive Health Digital Health & AI Hall 7
09:00–09:15 Keynote Reimagining Commercialization in an AI-Native World Market Access & Comm. Hall 6
09:10–09:40 Panel Discussion Where Biotech Value Is Being Created Today BD&L & Investment Hall 2 Panel Discussion The Evolving Role of Medical Affairs in Evidence Generation Medical & Regulatory Hall 4 Panel Discussion CMC as a Value Driver: What "Ready" Looks Like by Stage Manufacturing & Supply Hall 5
09:15–09:45 Panel Discussion Bridging the Translational Gap: Discovery to Clinical Proof Research & Discovery Hall 1 Panel Discussion Market Access Strategy in a Multi-Stakeholder Environment Market Access & Comm. Hall 6
09:25–10:00 Panel Discussion Patient-Centric Clinical Trials: Recruitment & Retention Clinical Development Hall 3 Panel Discussion Generative AI in Biopharma: Productivity Without Compliance Risk Digital Health & AI Hall 7
09:45–10:30 Showcasing Company Pitch 1 Research & Discovery Hall 1 Panel Discussion Funding Strategy: Early-Stage Biotech Must Be Investable BD&L & Investment Hall 2 Showcasing Company Pitch 1 Clinical Development Hall 3 Showcasing Company Pitch 1 Medical & Regulatory Hall 4 Showcasing Company Pitch 1 Manufacturing & Supply Hall 5 Showcasing Company Pitch 1 Market Access & Comm. Hall 6 Keynote Keynote Presentation Digital Health & AI Hall 7
10:30–11:30 Mid Morning Coffee Break  |  Networking & Refreshments  |  Discovery Hall
11:30–12:00 Panel Discussion Transforming Small Molecule Discovery: AI & Predictive Science Research & Discovery Hall 1 Panel Discussion What Defines an Investable Biotech Now: Team, Timing, Traction BD&L & Investment Hall 2 Panel Discussion AI in Clinical Trials: Operational Intelligence & Risk Management Clinical Development Hall 3 Panel Discussion Accelerated Regulatory Pathways: FDA Strategy & Fast-Track Medical & Regulatory Hall 4 Panel Discussion Manufacturing Excellence: Cost Efficiency, Quality & Global Scale-Up Manufacturing & Supply Hall 5 Panel Discussion RWE & HEOR: Demonstrating Value for Payers & HTA Bodies Market Access & Comm. Hall 6 Panel Discussion AI-Powered Patient Engagement & Personalized Care Digital Health & AI Hall 7
11:50–12:20 Panel Discussion RNA Therapeutics: Unlocking the Next Wave of Medicines Research & Discovery Hall 1 Panel Discussion Fundraising Strategy: Pricing, Syndicates & Tranched Rounds BD&L & Investment Hall 2 Panel Discussion Optimising Clinical Trial Feasibility: Site Selection & Access Clinical Development Hall 3 Panel Discussion Medical Affairs as a Strategic Partner: Cross-Functional Alignment Medical & Regulatory Hall 4 Showcasing Company Pitch 2 Manufacturing & Supply Hall 5 Panel Discussion Launch Excellence: Building Successful Commercialization Strategies Market Access & Comm. Hall 6 Panel Discussion Remote Patient Monitoring & Decentralized Healthcare Digital Health & AI Hall 7
12:20–12:40 Panel Discussion Targeted Protein Degradation & Emerging Modalities Research & Discovery Hall 2 Panel Discussion Investor Due Diligence: Red Flags That Quietly Kill Rounds BD&L & Investment Hall 2 Panel Discussion AI Transformation in Clinical Trials: Risk & Performance Clinical Development Hall 3 Showcasing Company Pitch 2 Medical & Regulatory Hall 4 Showcasing Company Pitch 2 Manufacturing & Supply Hall 5 Panel Discussion Pricing for Innovation Under Pressure: Defending Value Market Access & Comm. Hall 6 Showcasing Company Pitch 2 Digital Health & AI Hall 7
13:00–14:00 Lunch Break  |  Hot food & cold drinks will be served
14:00–18:00 Networking, Pre-Arranged Meetings, Exhibitions & Food/Beverages
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 2

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
Chairman's Address
  • 08:30 - 08:40
  • Hall 2

Chairman's Address

Dimitri F. Dimitriou, FRSM, FRSC, FRSB
Chairman U.S Biotech Day

16 Nov
pharma investor conference biotech - U.K.
  • 08:45 - 09:10
  • Hall 2

Collaborate or Collapse – Why Partnerships Have Become the Lifeline of Biotech Innovation

Speakers
Michael J. George

Michael J. George, CA-AM, MBA | Senior Director, Strategic Partnerships, Go To Market - Global Omnichannel | Sanofi

Sarah Tao

Sarah Tao | Senior Director, Search and Evaluation | CSL

Rachel Gaskell

Rachel Gaskell | Senior Director Business Development, Alliance Management | GSK

Leena Chaudhuri

Leena Chaudhuri, PhD | Senior Director, Early Pipeline & BD, Global Medical Oncology | Merck Healthcare

Valeria Pavet

Valeria Pavet | Head of the Translational Research Unit | Cancer Research UK (CRUK)

16 Nov
pharma investor conference biotech - U.K.
  • 09:10 - 09:25
  • Hall 2

Where Biotech Value Is Being Created Today and What Buyers Are Looking For?

Speakers
Debbie Drane

Debbie Drane | Head of Business Development, Therapeutic Areas | CSL

Laura Holberger

Laura Holberger | External Innovation Sourcing Director | Novo Nordisk

Brian Miglionico

Brian Miglionico | Vice President of Business Development | Agios Pharmaceuticals

16 Nov
pharma investor conference biotech - U.K.
  • 09:25 - 09:45
  • Hall 2

Rethinking Risk, Value and Deal Structures in an Increasingly Competitive Market

Moderator
Katherine Kendrick

Katherine Kendrick, CSAP | Executive Director, Head of Alliance Management | Jazz Pharmaceuticals

Speakers
Navin Swaroop

Navin Swaroop | Executive Director, Global Business Development, Neurology & Immunology | Merck KGaA, Darmstadt, Germany

Pulkit Guglani

Pulkit Guglani | Director BD&L Insights and Decision Sciences | Novartis

Ian Greenberg

Ian Greenberg | VP & Head of Business Development, Global Pharmaceuticals Commercial Portfolio | GSK

16 Nov
Keiretsu Forum-MST
  • 09:45 - 10:10
  • Hall 2

Personalized Panel Discussion: Funding Strategy: Good Science Is Not Enough. Early-Stage Biotech Companies Must Be Investable At All Milestones

Interactive discussion with industry experts.

Moderator
Howard Lubert

Howard Lubert | Regional President | Keiretsu Forum-MST

Speakers
Christian Haller

Christian Haller | Vice President Mid-Atlantic and Southeast Regions | Keiretsu Forum-MST

Benjamin R. Cowen

Benjamin R. Cowen, PhD, MBA | President, CEO and Co-founder | TicTwo Therapeutics

Maureen L. Mulvihill

Maureen L. Mulvihill, PhD | President & CEO | Actuated Medical, Inc

Dr. Krystle Karoscik

Dr. Krystle Karoscik | Chief Executive Officer | INNOVOTEX INC.

Keiretsu Forum
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:10 - 10:30
  • Hall 2

Company Pitch 1

Presentations by Sponsoring Companies.

10:10 – 10:30
Showcasing 1: J Craig Pharma
16 Nov
Valuation Panel
  • 11:30 - 12:00
  • Hall 2

What Defines an Investable Biotech Now: Team, Timing, Traction & Data

Moderator
Dr. Stella K. Vnook

Dr. Stella K. Vnook | Managing Partner & Founder | AVIVA VENTURES

Speakers
Jim Gunton

Jim Gunton | Managing Partner | Tech Council Ventures

Christiane Wherry

Christiane Wherry | Principal/Senior Investment Director | Arrow Ventures

Jimmy Melton

Jimmy Melton | General Partner | Cape Fear Biocapital

Paola Torre

Paola Torre, PhD | Venture Partner | Aquillius Ventures

Vivian Mingyue Li

Vivian (Mingyue) Li, Ph.D., MBA | Early Stage Investor | K2 Bio Partners

Charlene Kuo

Charlene Kuo | General Partner | Coddle Creek Capital

16 Nov
VC Panel
  • 12:00 - 12:30
  • Hall 2

Fundraising Strategy: Pricing, Syndicates, Tranched Rounds & Extensions

Moderator
Paul Anthony Claxton

Paul Anthony Claxton | Managing Partner | Digerati Investments

Speakers
Doc Parghi

Doc Parghi | Managing Partner | SRI Capital

Nate Kline

Nate Kline | Managing General Partner | Cistern Capital

Jeffrey Steckler

Jeffrey Steckler | Principal and Founder | Pontiva Healthcare Partners

Daniela Bendor

Daniela Bendor | Founder & Managing Partner | IDGB Capital

Michele Washko

Michele Washko | President & CEO | Life Sciences Greenhouse Investments

Harish Nanjala

Harish Nanjala | Head of Strategy & Operations and Chief of Staff to CEO | Beyond Alpha Ventures

16 Nov
Alternative Funding Panel
  • 12:30 - 13:00
  • Hall 2

Investor Due Diligence: Red Flags That Quietly Kill Rounds

Moderator
Michael Magliochetti

Michael Magliochetti, Ph.D. | Operating Partner | RS2 Healthcare Partners

Speakers
Ziad Sabry

Ziad Sabry | Associate | Good Growth Capital

Laurent Metz

Dr Laurent Metz MD MBA | Partner | Robin Hood Ventures

Crystal Donelan

Crystal Donelan | Healthcare Investor & Advisor | HealthTech Capital

Soyoung Park

Soyoung Park | General Partner | 1004 Venture Partners

Remy Goldstein

Remy Goldstein | Partner | Venture University

Christina J. Ansted

Christina J. Ansted, MPH, CCMEP | CEO and co-founder | Rapid Commercialization Partners

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 2

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:40 - 08:45
  • Hall 2

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
pharma investor conference biotech - U.K.
  • 08:45 - 09:15
  • Hall 2

How to get in Front of the Right Partner at the Right Time and Turning Interest into Opportunity?

Moderator
Albert Pat Fetaya

Albert "Pat" Fetaya | Partner | Princeton Global BioPharma Advisors, LLC

Speakers
Kiichiro Yano

Kiichiro Yano, Ph.D. | Deputy Head of Research Institute Boston | Daiichi Sankyo, Inc

Nicola La Monica

Nicola La Monica | Senior Director, Strategic Search and Evaluation | Johnson & Johnson

BingLing XU

BingLing XU, PhD, MBA | Director, Business Development & Strategic Alliance (Cardiovascular-Renal-Metabolic Diseases) | Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Caroline Stafford

Caroline Stafford | Head of International Partner Markets (IPM) & Head of Alliance Management | Norgine

17 Nov
pharma investor conference biotech - U.K.
  • 09:15 - 09:45
  • Hall 2

Early-Stage vs. Late-Stage Assets: Where’s the Sweet Spot?

Speakers
Neeraj Kumar

Neeraj Kumar | Director, Integrated Field Targeting and NBA | Novartis

Claudia Generaux

Claudia Generaux, PhD, MBA | Director, Business Development, Search & Evaluation | Bristol Myers Squibb

Yacine M. AMRANI

Yacine M. AMRANI | Senior Director Business Development_Search & Evaluation | SUN Pharma

Wei Shao, Ph.D.

Wei Shao, Ph.D. | Director Business Development and Strategy | Alexion Pharmaceuticals, Inc.

17 Nov
pharma investor conference biotech - U.K.
  • 09:45 - 10:10
  • Hall 2

Alliance & Deal Dynamics: How Big Pharma, Biotech & Partners Shape the Innovation Pipeline

Moderator
Nicole St Jean

Nicole St Jean | Executive Director, Business Development & Alliance Management | BioNTech SE

Speakers
Tarun Walia

Tarun Walia | Senior Director, R&D External Innovation Pipeline Filling and Sourcing | Novo Nordisk

Vishal Saxena

Vishal Saxena (PhD, MBA) | Sr. Director, Business Development, Integration, & Alliance, Global Product Development & Supply | Bristol Myers Squibb

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:10 - 10:30
  • Hall 2

Company Pitch 2

Presentations by Sponsoring Companies.

10:10 – 10:30
Company Presentation
17 Nov
Term Sheets Panel
  • 11:30 - 12:00
  • Hall 2

Asset, Platform, or Company: What Are Investors Backing Now?

Moderator
Andrew Meadow

Andrew Meadow | Partner & Chief Investment Officer | Health Innovation Capital

Speakers
Marcos Villa

Marcos Villa | Principal | Escher Innovations

Brian Carlisle

Brian Carlisle, MBA | Managing Partner | Carlisle Strategic Partners

Megha Unhelkar

Megha Unhelkar, PhD | Director of Investments | Connecticut Innovations

Scott Reese

Scott Reese | Executive Board Member | M3 Group Holdings

17 Nov
Global Capital Panel
  • 12:00 - 12:30
  • Hall 2

AI in Biotech Investment: Are Investors Backing Technology, Platforms or Clinical Proof?

Speakers
Urvashi Bhatnagar

Urvashi Bhatnagar, DPT, MBA | Managing General Partner | The Good Science Fund

Fiona Fanny Miller

Fiona (Fanny) Miller | Managing Partner | quadraScope Ventures

Gwen Cheni

Gwen Cheni | Director (Investments) | Connecticut Innovations

Alaina Percival

Alaina Percival | Venture Partner | Valor Ventures

Lorenzo Pellegrini

Lorenzo Pellegrini, Ph.D. | Managing Partner | Hatch Biofund

17 Nov
Risk Mitigation Panel
  • 12:30 - 13:00
  • Hall 2

Acquisition, IPO or Independence: What Is the Optimal Exit Path for Biotech Companies?

Moderator
Jay Roberts

Jay Roberts | Partner | Ventac Partners

Speakers
Alexander Dugom

Alexander Dugom | General Partner | InoSwift Capital Fund

Ellen S. Baron

Ellen S. Baron | Managing Director, Biopharmaceuticals | Outcome Capital

Cynthia (Xiao-jia) Cai

Cynthia (Xiao-jia) Cai | Founder and Principal | Viva BioInnovator

David Zhu

David Zhu | Founding Partner | Kendall Capital Partners

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 1

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 1

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
novel drug modalities
  • 08:45 - 09:15
  • Hall 1

Target Identification in 2026: Human Genetics, Functional Genomics & Causal Biology

Speakers
Giusy Della Gatta

Giusy Della Gatta | Associate Director - Oncology/Immune - oncology | Regeneron

Pichai Raman

Pichai Raman | Senior Director, Computational Biology | Incyte

Marla Weetall

Marla Weetall | Sr. Vice President, Pharmacology and Biomarkers | PTC Therapeutics

Aco Radujevic

Aco Radujević, Ph.D. | Principal Scientist, Data, Automation & Predictive Science | GSK

Jochen Schmitz

Jochen Schmitz | Executive Director, Immunology & Respiratory Disease Research | Boehringer Ingelheim

Suma Gopinathan

Suma Gopinathan, PhD | Senior Vice President, Discovery | Lexicon Pharmaceuticals, Inc.

16 Nov
Bridging the Translational Gap
  • 09:15 - 09:45
  • Hall 1

Bridging the Translational Gap: From Discovery Insights to Clinical Proof

Speakers
Manfred Stapff

Manfred Stapff, MD, PhD | Clinical Development Senior Director | Pfizer

Abhirami Suresh

Abhirami Suresh | Associate Scientist, Postdoctoral Fellow | Merck

Nina Tong

Nina Tong | Senior Research Investigator, Clinical Pharmacology and Pharmacometics | Bristol Myers Squibb

Amanda Ouchida

Amanda Ouchida | Senior Scientist | Takeda

Abhijeet R Patil

Abhijeet R Patil, Ph.D. | Sr. Manager, Data Science, Translational & Precision Medicine | Teva Pharmaceuticals

Maria L. Maccecchini

Maria L. Maccecchini, PhD | Chief Executive Officer | Annovis Bio, Inc

Manjunatha Shivaraju

Manjunatha Shivaraju | Principal Scientist/Lab Head, Material and Analytical Science Department | Boehringer Ingelheim

Theresa Funk

Theresa Funk | Associate Director, Early Translational Development | LifeMine Therapeutics

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 1

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
advanced disease models
  • 11:30 - 11:50
  • Hall 1

Transforming Small Molecule Discovery: AI, Computational Chemistry and Predictive Science

Speakers
Deepa Korani

Deepa Korani | Machine Learning Scientist | Novo Nordisk

Aubhishek Zaman

Aubhishek Zaman, PhD | Senior Scientist | Merck

Pablo Trigo Mourino

Pablo Trigo Mouriño | Senior Principal Scientist | Pfizer

Mahmoud Shobair

Mahmoud Shobair | Principal Data Scientist | Johnson & Johnson

16 Nov
RNA Therapeutics
  • 11:50 - 12:20
  • Hall 1

RNA Therapeutics: Unlocking the Next Wave of Medicines

Speakers
Jayharsh Panchal

Jayharsh Panchal | Director Bioanalytics | Hemab therapeutics

Zhiyi (Zoey) Zheng

Zhiyi (Zoey) Zheng | Principal Scientist, Omics Sciences, Target Discovery | GSK

Dmitry Samarsky

Dmitry Samarsky, PhD | Co‑Founder, Chief Scientific Officer and Board Director | ARNAgen™ Therapeutics

Julian Grundler

Julian Grundler | Senior Scientist, Vaccine Drug Product Development | AstraZeneca

Yun-Ting Kao

Yun-Ting Kao | Senior Scientist | Immunomic Therapeutics, Inc.

16 Nov
Cell & Gene Therapy Panel
  • 12:20 - 12:40
  • Hall 1

Targeted Protein Degradation & Emerging Modalities: Expanding the Therapeutic Landscape

Speakers
Tauseef Butt

Tauseef Butt | President and CEO | Progenra

Johanna Mora

Johanna Mora | Executive Director of Bioanalytical Sciences | Biohaven Pharma

Li Zhang

Li Zhang, M.D., Ph.D., EMBA, FCP | Director, Quantitative Clinical Pharmacology | Daiichi Sankyo US

Marina Nelen

Marina Nelen | Vice President, Head of Drug Discovery | Foghorn Therapeutics Inc.

Shilpa Kadam

Shilpa Kadam | Senior Director Global Translation Medicine Lead | Astellas Pharma

16 Nov
Next-Gen Biologics Panel
  • 12:40 - 13:00
  • Hall 1

Cell & Gene Therapy Revolution: From Science to Scalable Manufacturing

Speakers
Marianna Sabatino

Marianna Sabatino | VP Process Sciences, Analytics and Technology | Astrazeneca

Yan Zhi

Yan Zhi, Ph.D. | Director, S&I Lead | CSL Behring

Parv Barot

Parv Barot | Associate Scientist | Amneal Pharmaceuticals

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 1

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 1

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
research data integration
  • 08:45 - 09:15
  • Hall 1

From Biology to IND: Advancing Preclinical Innovation and Drug Development Strategies

Speakers
May Freag

May Freag | Associate Director | Takeda

Stella Berendam

Stella Berendam, Ph.D. | Associate Director - Immunotoxicology | Astrazeneca

Meredith Crosby

Meredith Crosby, PhD, DABT | Associate Director, Toxicology | Regeneron

Alexander Armstrong

Alexander Armstrong | Process Development Senior Scientist | Amgen

Xilu Jiao

Xilu Jiao | Director, S&E, Global Business Development,OPDC, Otsuka Pharmaceuticals | Otsuka Pharmaceutical Companies (U.S)

Jamila Siamwala

Jamila Siamwala | Neuroinflammation Discovery, Disease Modelling and Assay Development Scientist | Merck

Swati Arora

Swati Arora, Ph.D. | Advisor-Technical Operation, Mixed Modalities-Lilly Medicine Foundry | Eli Lilly and Company

Judy Bushong

Judy Bushong | Director, Clinical Scientist Lead | Bristol Myers Squibb

Kasinath Kuravi

Kasinath Kuravi | Sr. Manager, Functional Genomics & Bioinformatics | United Therapeutics

17 Nov
research data integration
  • 09:15 - 09:45
  • Hall 1

Beyond the Hype: AI's Next Frontier in Drug Development

Speakers
Matthew Clark

Matthew Clark | Vice President of Data Science | Ability Biotherapeutics

Shobana Shanmugasundaram

Shobana Shanmugasundaram | Senior Principal Scientist | Bristol Myers Squibb

Azim Dehghani Amirabad

Azim Dehghani Amirabad | Principal Artificial Intelligence Scientist II | Johnson & Johnson Innovative Medicine

Anders Nelson

Anders Nelson | Senior Computational Biologist, Oncology Data Science | AstraZeneca

Simone (Bigi) Botterill

Simone (Bigi) Botterill | Principal Scientist, Medicinal Chemistry | Recursion

Harlinson Estheban Osorio Franco

Harlinson Estheban Osorio Franco | Associate Scientist, Genomics | United Therapeutics

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 1

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
early stage research funding
  • 11:30 - 11:50
  • Hall 1

Biomarkers That Matter: From Hypothesis to Decision-Grade Evidence

Speakers
Roshanak Tolouei Semnani

Roshanak Tolouei Semnani | Executive Director Translational Research | Precigen

Anna Moore

Anna Moore Ph.D. | Principal Scientist, Pharmacology and Biomarkers | PTC Therapeutics, Inc.

Shantanu Shewale

Shantanu Shewale, PhD | Associate Director, Companion Diagnostics | Regeneron

Raluca Budiu-Predoiu

Raluca Budiu-Predoiu | Director - Precision Medicine IO | Abbvie

Pravin Kesarwani

Pravin Kesarwani | Principal Scientist | BriaCell Therapeutics Corp.

17 Nov
Next-Gen Biologics Panel
  • 11:50 - 12:10
  • Hall 1

Next-Generation Biologics: Expanding Beyond Antibodies

Speakers
Emilie Duvallet

Emilie Duvallet | Principal scientist, Immunometabolism | Novo Nordisk

Lin Huang

Lin Huang | Senior Principal Scientist | Pfizer

Timothy Phillips

Timothy Phillips | Senior Researcher | Eisai US

Rachel Tam

Rachel Tam | Associate Director, Precision Medicine | Kura Oncology, Inc.

17 Nov
Immunotherapy Panel
  • 12:10 - 12:30
  • Hall 1

Novel Delivery Systems: LNPs, Viral Vectors & Emerging Alternatives

Speakers
Manjunatha Shivaraju

Manjunatha Shivaraju | Principal Scientist/Lab Head, Material and Analytical Science Department | Boehringer Ingelheim

Pedro J Cejas

Pedro J Cejas | Senior Director - Discovery, Delivery Platforms | Roche

Beyza Bulutoglu

Beyza Bulutoglu, Ph.D. | Senior Principal Scientist | Genentech

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 3

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 3

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
decentralized clinical trials
  • 08:55 - 09:25
  • Hall 3

Designing High-Quality Clinical Trials: Protocol Design, Data Integrity & Regulatory Confidence

Moderator
Judith Inumerable

Judith Inumerable, DMSc, MBEE | Senior Director, Clinical Scientist | Syndax Pharmaceuticals

Speakers
Evelyn Guo

Evelyn Guo | Medical Director | Genmab

Paramahamsa Maturu

Paramahamsa Maturu, PhD | Associate Directorc - Clinical Development-Oncology (Clinical Science) | Daiichi Sankyo

Kissondra Morris

Kissondra (Mateuszczyk) Morris, MS, MBA | Associate Director: Protocol Review Committee Lead | Bristol Myers Squibb

Cindy Joanne Mazur

Cindy Joanne Mazur | Senior Clinical Research Scientist - Oncology | Genmab

Kasturi Banerjee

Kasturi Banerjee, PhD | Senior Clinical Scientist | CSL

16 Nov
decentralized clinical trials
  • 09:25 - 10:00
  • Hall 3

Patient-Centric Clinical Trials: Designing for Recruitment, Experience & Retention

Speakers
Anu Walia

Anu Walia | Senior Clinical Operations Leader | Genentech

Mark Webb

Mark Webb, PhD | Associate Director of Clinical Research | Pentixapharm Holding AG

Ali Manouchehri

Ali Manouchehri, MD, MPH | Clinical Development Medical Director | Pfizer

Catherine A. Click

Catherine A. Click | Director, Clinical Site Payments | Vertex Pharmaceuticals

Amit Raval

Amit Raval, PhD | Director, Real World Evidence , Oncology | Bayer

Nikki Thomas

Nikki Thomas | Recruitment Strategist (Associate Director) | Pfizer

Urvi Jatania

Urvi Jatania, MS, MBA | Director, Operations Portfolio Lead Global Clinical Trial Strategy & Operations | Bristol Mayers Squibb

Dr. Christopher Gantz

Dr. Christopher Gantz | Patient Engagement, Experience and Recruitment | Takeda

Kimbra Edwards

Kimbra Edwards, PhD | Senior Director, Health Communication Services | CISCRP

Mitra Tavakkoli

Mitra Tavakkoli, MD, PharmD | VP Clinical Development & Head of Pharmacovigilence | Sangamo Therapeutics, Inc

Sonya Abraham

Sonya Abraham | Senior Director Translational & Global Clinical Development | CSL Behring

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:00 - 10:30
  • Hall 3

Company Pitch 1

Presentations by Sponsoring Companies.

10:00 – 10:15
Company Presentation 1
10:15 – 10:30
Company Presentation 2
16 Nov
patient centric clinical trials
  • 11:30 - 12:00
  • Hall 3

AI in Clinical Trials: Driving Operational Intelligence, Risk Management & Trial Performance

Moderator
Narayanarao Pavuluri

Narayanarao Pavuluri | Senior Director, Global Head of Clinical Database Services | Merck

Speakers
Richard Bobek

Richard Bobek | Associate Director, Clinical Data Science | MSD

Shivanjali Kumar

Shivanjali Kumar | Associate Director, Product Management | Merck

Raghav Rajagopalan

Raghav Rajagopalan | Third Party Quality Lead GCP - Director | Pfizer

James Kirwin

James Kirwin | COO and Sr VP, Clinical Development | SFA Therapeutics

Imran Rashid

Imran Rashid | Head Programming Center of Excellence | CSL

Nobendu Roy

Nobendu Roy | Associate Director Senior IT Business Partner - Clinical Analytics, Biostat and Data Management | Otsuka Pharmaceutical Companies (U.S.)

Naveen Kumar Chiranji

Naveen Kumar Chiranji, PMP | Senior Clinical Data programmer | Eikon Therapeutics

Sreenivas Reddy

Sreenivas Reddy (Sree) | Associate Director Clinical Operations | Novo Nordisk

Tejal Nadkarni

Tejal Nadkarni | Senior Clinical Operations Leader | CSL Behring

Oscar L. Kashala

Oscar L. Kashala, MD, PhD, DSc | President & Chief Medical Officer | Therabene, Inc

Maurice Lobo

Maurice Lobo | Director, Oncology Clinical Development | Bristol Myers Squibb

N. Kofi Addo

N. Kofi Addo, MPH | Snr. Manager, Clinical Quality Oversight and Risk Management | Shionogi Inc.

Sharri H. Adams-Edwards

Sharri H. Adams-Edwards | Executive Director Clinical Operations | Eli Lilly and Company

16 Nov
patient centric clinical trials
  • 12:00 - 12:30
  • Hall 3

Optimising Clinical Trial Feasibility: Site Selection, Patient Access & Operational Readiness

Speakers
LaShell Robinson

LaShell Robinson | Executive Director, Head Global Feasibility & Trial Equity | Takeda

Carla Charles

Carla Charles | Associate Director, Global Clinical Operations | Bristol Myers Squibb

Shiwani Tiwari

Shiwani Tiwari | Clinical Trial Manager | Genmab

Sherrita Dorsey

Sherrita Dorsey, MSN FNP RN | US Head Patient and Professional Advocacy | Amicus Therapeutics

Chaitali Tripathi

Chaitali Tripathi | Transformational clinical operations leader and Head of Study Readiness | Alnylam Pharmaceuticals

Jesselle Simeon

Jesselle Simeon | Director, Clinical Operations and Contracts Management | Adverum Biotechnologies

16 Nov
patient centric clinical trials
  • 12:30 - 13:00
  • Hall 3

AI Transformation in Clinical Trials: Driving Operational Intelligence, Risk Management & Trial Performance

Speakers
James Kirwin

James Kirwin | COO and Sr VP, Clinical Development | SFA Therapeutics

Imran Rashid

Imran Rashid | Head Programming Center of Excellence | CSL

Nobendu Roy

Nobendu Roy | Associate Director Senior IT Business Partner - Clinical Analytics, Biostat and Data Management | Otsuka Pharmaceutical Companies (U.S.)

Naveen Kumar Chiranji

Naveen Kumar Chiranji, PMP | Senior Clinical Data programmer | Eikon Therapeutics

Sreenivas Reddy

Sreenivas Reddy (Sree) | Associate Director Clinical Operations | Novo Nordisk

Tejal Nadkarni

Tejal Nadkarni | Senior Clinical Operations Leader | CSL Behring

Shashidar Reddy Abbidi

Shashidar Reddy Abbidi | Manager Clinical Data Management | Bristol Myers Squibb

Garrett Manasco

Garrett Manasco | Associate Director, Clinical Artificial Intelligence - Data and Medical Monitoring | Abbvie

Narayanarao Pavuluri

Narayanarao Pavuluri | Senior Director, Global Head of Clinical Database Services | Merck

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 3

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 3

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 May
Keynote
  • 09:00 - 09:15
  • Hall 3

Reimagining Clinical Trials: From Sites and Systems to a Patient-First Future

Yana Matiychuk

Associate Director, Clinical Operations Program Lead

Legend Biotech

17 Nov
global clinical trials
  • 09:15 - 09:45
  • Hall 3

Accelerating Clinical Development: Optimising Trial Strategy, Efficiency & Decision-Making

Speakers
Michelle Lim-Watson

Michelle Lim-Watson | VP, Clinical Development & Program Leadership, CVD & Rare Diseases | Novo Nordisk

Haichen Yang

Haichen Yang | Vice President, Clinical Research | Amicus Therapeutics

Amuche Anakor

Amuche Anakor MD MRCGP | Director, Clinical Development Immunology | Johnson & Johnson Innovative Medicine

Eleni Lagkadinou

Eleni Lagkadinou, MD PhD | Vice President, Head of Oncology Early Development (OED) | Abbvie

Maurice Lobo

Maurice Lobo | Director, Oncology Clinical Development | Bristol Myers Squibb

Aarti Sawant

Aarti Sawant | Group Director | AstraZeneca

Oscar L. Kashala

Oscar L. Kashala, MD, PhD, DSc | President & Chief Medical Officer, Therabene, Inc. | Therabene, Inc

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 09:45 - 10:30
  • Hall 3

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
global clinical trials
  • 11:30 - 12:00
  • Hall 3

Strategic Partnerships in Clinical trials: Choosing the Right CROs, Vendors, and Collaborators

Moderator
Sudeesh Tantry

Sudeesh Tantry | Disease Area Head, Global Clinical Development | Teva Pharmaceuticals

Speakers
Susan Neal

Susan Neal | Senior Director, Clinical Operations | Novavax

Mudgal Kothekar

Mudgal Kothekar | Vice President Clinical Development | Sun Pharma Advanced Research Company Ltd. (SPARC)

Ashley Magnavita

Ashley Magnavita | Associate Director, Clinical Operations | Madrigal Pharmaceuticals, Inc.

Smita Raghava

Smita Raghava, Ph.D. | Principal Scientist | Merck

Sharri H. Adams-Edwards

Sharri H. Adams-Edwards | Executive Director Clinical Operations | Eli Lilly and Company

17 Nov
CRO partnerships
  • 12:00 - 12:30
  • Hall 3

Beyond Traditional Trials: Using RWE & Synthetic Controls to Accelerate Clinical Evidence Generation

Moderator
Anbu Damodaran

Anbu Damodaran | Associate Director of Statistical Programming at AstraZeneca | Astrazeneca

Speakers
Jing Dai

Jing Dai | Director of Biostatistics, Evidence and Value Generation | Jazz Pharmaceuticals

Lauren Young

Lauren Young | Associate Director, Real-World Data Strategy, Diabetes | Novo Nordisk

Paul Chuku

Paul Chuku | Senior Clinical Research Associate | Merck

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 3

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 4

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 4

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
Keynote
  • 08:45 - 09:00
  • Hall 4

From Reactive to Predictive: Modernizing Regulatory Affairs as a Value Engine

Shaily Arora

Vice President Regulatory Affairs

Menarini Stemline

16 Nov
real world evidence
  • 09:00 - 09:35
  • Hall 4

The Evolving Role of Medical Affairs in Evidence Generation & Scientific Communication

Moderator
Jens Hildebrandt

Jens Hildebrandt | Medical Impact & Effectiveness Lead | Bayer

Speakers
Stefan Kolata

Stefan Kolata | Global Medical Director | Jazz Pharmaceuticals

Rushi Potdar

Rushi Potdar, MBBS MBA | Chief Medical Officer; VP of Global Medical Affairs -Oncology Business Unit | Takeda

Thihan Padukkavidana

Thihan Padukkavidana PhD | Executive Director, Medical Affairs | Bicara Therapeutics

Peter Gin-Fu Chen

Peter Gin-Fu Chen, PhD | VP, Head of North America Medical | Biogen

Pooja Shah

Pooja Shah | Associate Director, Global Medical Affairs- Scientific Communications | Alnylam Pharmaceuticals

Joanne Rizzo

Joanne Rizzo | US Strategy Lead Director, Medical Affairs | Merck

16 Nov
real world evidence
  • 09:35 - 10:05
  • Hall 4

Real-World Evidence (RWE): From Data Generation to Regulatory Decision-Making

Moderator
Jamie Partridge Grossman

Jamie Partridge Grossman, PhD, MBA | National Director, HEOR | Bayer

Speakers
Michael J. Doane

Michael J. Doane, Ph.D. | Executive Director, Head of HEOR | Alkermes

Michelle Hillsman Sanders

Michelle Hillsman Sanders | Director, Global Regulatory Strategy | Otsuka Pharmaceutical Companies (U.S.)

Dr. Giulia Ghibellini

Dr. Giulia Ghibellini | Senior Director II, Patient Focused Medical Engagement Lead, Global Medical Affairs, Innovative Medicines R&D | Teva Pharmaceuticals

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:05 - 10:25
  • Hall 4

Company Pitch 1

Presentations by Sponsoring Companies.

10:05 – 10:25
Company Presentation 1
16 Nov
patient engagement
  • 11:30 - 12:00
  • Hall 4

Accelerated Regulatory Pathways: FDA Strategy, Fast-Track Approvals & Global Alignment

Moderator
Andrew Kelleher

Andrew Kelleher, PhD, MS, RAC | Associate Director, U.S. Regulatory Policy | Novartis

Speakers
Adam Runkle

Adam Runkle, MRA, ML | Director, US Regulatory Intelligence and Policy | Daiichi Sankyo US

Bish Sahoo

Dr. Bish Sahoo | CMC Global Regulatory Affairs Strategy Lead | Takeda

Shaily Arora

Shaily Arora | Vice President Regulatory Affairs | Menarini Stemline

Bhargav Vyas

Bhargav Vyas | Sr. Manager / Sr. Scientist, Global Regulatory CMC Product Lead | Organon

16 Nov
global regulatory compliance
  • 12:00 - 12:30
  • Hall 4

Medical Affairs as a Strategic Partner: Cross-Functional Collaboration – Strategy & Alignment

Moderator
Roberta Luzzi

Roberta Luzzi | Senior Global Medical Director Portfolio, Rare Haematology, Immunology, Dermatology, Ophthalmology | Chiesi Group

Speakers
Wendy Boivin

Wendy Boivin, PhD | Associate Director, Global Medical Strategy | CSL Seqirus

Matthew Baker

Matthew Baker, PharmD, BCMAS | Senior Medical Science Liaison | Bristol Myers Squibb

Mark Mikhail

Mark Mikhail | Director, US Medical Content Creation Strategy and Development, C3C lead | Bayer

Porsche Loring

Porsche Loring | Global Medical Lead, Neurotrophic Keratitis (NK) Lifecycle Management and Persistent Corneal Epithelial Defect (PCED) | Dompé

Emre Baser

Emre BAŞER, MD | Director, Medical Diagnostics | AstraZeneca

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 4

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 4

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:30 - 08:40
  • Hall 4

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
advanced disease models
  • 09:00 - 09:15
  • Hall 4

Keynote Presentation 2

17 Nov
medical strategy
  • 09:15 - 09:45
  • Hall 4

Scientific Narrative That Lands: Publications, Congress & KOL Strategy

Moderator
Nabil Khan

Nabil Khan, MD | Internal Medicine Medical Director | Pfizer

Speakers
Samuel Fatoba

Samuel Fatoba | US Medical Affairs Head- GRC | BioMarin Pharmaceutical Inc

Stefan Kolata

Stefan Kolata | Global Medical Director | Jazz Pharmaceuticals

Jennifer Do

Jennifer Do, PharmD, MS | Associate Director, External Scientific Communications | Abbvie

Myriam Asmar

Myriam Asmar | Director of Medical Affairs – Insights & Strategic Engagement | Novo Nordisk

Cathy Duong

Cathy Duong PharmD | Senior Director, Medical Affairs Strategy | Summit Therapeutics, Inc.

Justine Kennedy

Justine Kennedy, PhD, CMPP | Associate Director, Medical Communications & Publications | Alnylam Pharmaceuticals

Clayton W. Snell

Clayton W. Snell | Field Medical Director - Neurology | Ionis Pharmaceuticals, Inc.

Hinna Shahid

Hinna Shahid, MD | Global Medical Affairs Lead | Bayer

17 Nov
medical strategy
  • 09:45 - 10:15
  • Hall 4

Medical Affairs as a Strategic Partner: Cross-Functional Collaboration – Implementation & Impact

Moderator
Ania Siedlecki

Ania Siedlecki, MD | Associate Medical Director, CAR-T & Myeloid Hematology | Johnson & Johnson Innovative Medicine

Speakers
Liam Lee

Liam Lee, Ph.D., MB(ASCP) | Senior Director, Medical Diagnostics - US Lung Cancer Dx Strategy Team Lead | AstraZeneca

Drew Rockett

Drew Rockett | Senior Director Medical Affairs, Insights & Analytics | Bayer

Hersh Gupta

Hersh Gupta, PharmD | Associate Director, Medical Science Liaison - Immunology | Novartis

Lorena Griparic

Lorena Griparic, Ph.D. | Medical Science Director, General Nephrology | Biogen

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:15 - 10:30
  • Hall 4

Company Pitch 1

Presentations by Sponsoring Companies.

10:15 – 10:30
Company Presentation 1
17 Nov
digital medical affairs
  • 11:30 - 12:00
  • Hall 4

The Future of Medical Affairs: AI, Digital Engagement & Next-Generation Medical Excellence

Moderator
Cathy Duong

Cathy Duong PharmD | Senior Director, Medical Affairs Strategy | Summit Therapeutics, Inc

Speakers
Marie-Ange Noue

Marie-Ange Noué, PhD, CMPP | President, phactMI | Former Senior Director & Head of North America Scientific Communications, EMD Serono | EMD Serono, Inc.

Renadin Siagat

Renadin Siagat

17 Nov
compliance and ethics
  • 12:00 - 12:30
  • Hall 4

Digital Regulatory Transformation: AI, Automation & the Future of Compliance

Moderator
Nandini Sabharwal

Nandini Sabharwal

Speakers
Hiroki Watarai

Hiroki Watarai, PharmD, MPA | Associate Director, Field Medical Affairs (Immunology) | Regeneron

Shabana Motlani

Shabana Motlani | Director | Novo Nordisk

Jyoti Balhara

Jyoti Balhara, PhD | Former Regulatory Affairs Manager | AstraZeneca

Subhayan Das

Subhayan Das | Director, Head- Business Insights & Technology, Patient Safety & Regulatory | Bristol Myers Squibb

Kia Donboli

Kia Donboli, MD | Director Medical Affairs | Ferring Pharmaceuticals

Jing Chien

Jing Chien, DNP, CRNP, AOCNP | Regional Medical Science Director | Summit Therapeutics, Inc.

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 4

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 5

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:50 - 08:55
  • Hall 5

Chairman's Address

Seif Eddine Derradji

Global Supply Chain Cross-Functional Specialist - GSC

AstraZeneca

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
supply chain risk management
  • 09:00 - 09:30
  • Hall 5

CMC as a Value Driver: What "Ready" Looks Like by Stage

Moderator
Manda Pasarkar

Manda Pasarkar, DTM | Global Regulatory Affairs CMC HEAD | Sanofi

Speakers
Gautam Pangu

Gautam Pangu (PhD, PMP) | Director, Biologics CMC Project Management | Incyte

Amit Katiyar

Amit Katiyar | Senior Director- Biologics Development & Manufacturing Operations | Exelixis

Paresma Patel

Paresma (Pinky) Patel | Director, Regulatory CMC Policy and Advocacy | Gilead Sciences

Bish Sahoo

Dr. Bish Sahoo | CMC Global Regulatory Affairs Strategy Lead | TAKEDA

16 Nov
sustainable manufacturing
  • 09:30 - 10:00
  • Hall 5

Building Resilient Pharma Supply Chains: Managing Disruption, Shortages & Global Risk Exposure

Moderator
Arthur L. Edge III

Arthur L. Edge III | Senior Director, Global Supply & Strategy - Respiratory & Immunology | Astrazeneca

Speakers
Seif Eddine Derradji

Seif Eddine Derradji | Global Supply Chain Cross-Functional Specialist - GSC | AstraZeneca

Tom OGara

Tom O'Gara | Head of Global Supply Chain Planning | BioMarin Pharmaceutical Inc.

Amit Joshi

Amit Joshi | Senior Director, Strategic Sourcing, Supply Chain | Iovance Biotherapeutics, Inc.

Eyad Salman

Eyad Salman | US Distribution Quality Director | Gilead Sciences

Jennifer Gormley

Jennifer Gormley | Executive Director, MRL Global Clinical E2E Supply | Merck

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:00 - 10:20
  • Hall 5

Company Pitch 1

Presentations by Sponsoring Companies.

10:10 – 10:30
Showcasing 1: Nordoon
16 Nov
CDMO partnerships
  • 11:30 - 12:00
  • Hall 5

Manufacturing Excellence in Pharma: Driving Cost Efficiency, Quality Compliance & Global Scale-Up

Moderator
Jeremy Peters

Jeremy Peters | Senior Manager - Cell Therapy Manufacturing Operations, Abecma | Bristol Myers Squibb

Speakers
Sai Kiran Camsarapalli

Sai Kiran Camsarapalli | Associate Director Supply Chain Material Planning | Bristol Myers Squibb

Kedar Shewalkar

Kedar Shewalkar | Quality Digital Innovation and Delivery Lead | Associate Director | Takeda

Caitlyn Stiteler

Caitlyn (Muldoon) Stiteler, MBA | Associate Director, Biologics Manufacturing | Teva Pharmaceuticals

Jared Casebeer

Jared Casebeer | Sr. Manager of External Manufacturing and CMC Lead | Immunome, Inc.

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:00 - 13:00
  • Hall 5

Company Pitch 2

Presentations by Sponsoring Companies.

12:00 – 12:20
Company Presentation 1
12:20 – 12:40
Company Presentation 2
12:40 – 13:00
Company Presentation 3
16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 5

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:50 - 08:55
  • Hall 5

Chairman's Address

Seif Eddine Derradji

Global Supply Chain Cross-Functional Specialist - GSC

AstraZeneca

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
CDMO partnerships
  • 09:00 - 09:30
  • Hall 5

Tech Transfer & Scale-Up: Reducing Risk in Clinical-to-Commercial Manufacturing Transitions

Moderator
Andy Halsey

Andy Halsey, PE | Senior Director, Biologics Manufacturing | Teva Pharmaceuticals

Speakers
J. Ashley Groves

J. Ashley Groves | Director, MSAT Upstream Laboratory Lead | BioNTech SE

Nazila Miller

Nazila Miller, Ph.D. | Former Director, Drug Product Development | Takeda

Cassidy Kerezsi Koch

Cassidy Kerezsi Koch | Manager, Process Technology & Manufacturing Systems | GSK

17 Nov
quality by design
  • 09:30 - 10:00
  • Hall 5

AI & Digital Supply Chains: From Demand Forecasting to Real-Time Operational Decision-Making

Moderator
Sheila Trgovac

Sheila Trgovac | Associate Director - US Supply Chain | Eli Lilly and Company

Speakers
Sandeep Dhar

Sandeep Dhar | Head of Center Global Category Management (Supply Chain Procurement) | Johnson & Johnson

Suzie Rawden

Suzie Rawden | Digital Strategy & Deployment, Director | Johnson & Johnson

Karthik Narayanan

Karthik Narayanan | Sr Director of Product Management | Eli Lilly and Company

Carol Shultz

Carol Shultz, PhD | Rotation in Global Clinical Trial Operations | Merck

Animesh Raut

Animesh Raut MS, MBA | Associate Director, Enterprise Quality Lab Systems | Bristol Myers Squibb

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:00 - 10:20
  • Hall 5

Company Pitch 2

Presentations by Sponsoring Companies.

10:10 – 10:30
Company Presentation 1
17 Nov
advanced manufacturing tech
  • 11:30 - 12:00
  • Hall 5

Cold Chain Excellence: Enabling Cell & Gene Therapies, Vaccines & High-Value Biologics Distribution

Speakers
Eric Elbel

Eric Elbel | Logistics Director | Avidity Biosciences

Seif Eddine Derradji

Seif Eddine Derradji | Global Supply Chain Cross-Functional Specialist - GSC | AstraZeneca

Pedro Rivera

Pedro Rivera

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:00 - 13:00
  • Hall 5

Company Pitch 2

Presentations by Sponsoring Companies.

12:00 – 12:20
Company Presentation 1
12:20 – 12:40
Company Presentation 2
12:40 – 13:00
Company Presentation 3
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
manufacturing packaging registration Philadelphia U.S conference
  • 07:30 - 08:30
  • Hall 6

Conference Registration

Registration, Badge Collection, Morning Coffee.

16 Nov
manufacturing packaging chairman address
  • 08:30 - 08:40
  • Hall 6

Chairman's Address

Saurav Gupta

Head of Global Digital Patient Services, Takeda

Takeda

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
Saurav Gupta
  • 09:00 - 09:15
  • Hall 6

Reimagining Commercialization in an AI-Native World

Saurav Gupta

Head of Global Digital Patient Services, Takeda

Takeda

16 Nov
patient centric sustainable packaging panel
  • 09:15 - 09:45
  • Hall 6

Market Access Strategy in a Multi-Stakeholder Environment: Aligning Evidence, Payers & Patient Access

Moderator
Nazanin Mehin

Nazanin Mehin🇨🇦🇫🇷 | Global Market Access and Pricing Head, Immunology | Sanofi

Speakers
Silky Beaty

Silky Beaty, PharmD, MSPH | Director of Payer Value & Outcomes | Jazz Pharmaceuticals

Harpreet Sandhu

Harpreet Sandhu | Former Executive Director, Market Access Cross Portfolio | Gilead Sciences

Cassaundra Johnson

Cassaundra Johnson, MSHA, RN, CMCN | Regional Payer Account Director | Organon

Valerie Mejia

Valerie Mejia | Director, US Market Access Marketing | Pfizer

Luis Hernandez

Luis Hernandez | VP, Head of Evidence Generation, Oncology | Takeda

Melissa Hagan

Melissa Hagan, PhD, MPH | Director, US Market Access Strategic Evidence, Oncology | BeOne Medicines

16 Nov
company pitch manufacturing solutions
  • 09:45 - 10:30
  • Hall 6

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
patient centric sustainable packaging panel
  • 11:30 - 12:00
  • Hall 6

Real-World Evidence (RWE) & HEOR: Demonstrating Value for Payers, HTA Bodies & Reimbursement to Support Market Access Decisions

Moderator
John Sears

John Sears, PhD, MBA | Senior Director, Hematology Global Commercial Development | CSL

Speakers
Farah Jivraj

Farah Jivraj | Head, Market Access, policy and stakeholder relations | Biogen, Canada

Antonia Electra Panayi

Antonia Electra Panayi | Head, Global Medical Evidence, Takeda | Takeda

Jamie Partridge Grossman

Jamie Partridge Grossman, PhD, MBA | National Director, Health Economics & Outcomes Research | Bayer

Ravi Iyer

Ravi Iyer | Sr. Director, Head of Centers of Excellence RWE, PRO, EPI, Value Communications Global Health Economics, Value and Outcomes (Global HEVO) | Teva Pharmaceuticals

Aurore Yocolly

Aurore Yocolly | Director, Global RWE & Health Outcomes Research - Specialty Medicines, Early Assets - Pipeline | GSK

16 Nov
scaling biologics and advanced therapies panel
  • 12:00 - 12:30
  • Hall 6

Launch Excellence in Pharma & Biotech: Building Successful Commercialization Strategies

Speakers
Susana Guitar Jimenez

Susana Guitar Jiménez | Global Market Access & Pricing Director, Biosimilars Lead (Organon LLC) | Organon LLC

Marvin Allen

Marvin Allen | Head of Trade Relations | SUN PHARMA

Vinicius Dantas Alves

Vinícius Dantas Alves | Associate Vice President & Global Brand Lead ASMD | Sanofi

Jason M. Noto

Jason M. Noto | Senior Vice President, US Market Access & Alliance Management | AVEO Oncology, an LG Chem company

Adeola Chukwumah

Adeola Chukwumah | Director Contract Strategy Oncology and Biosimilars | Pfizer

Jonny Betts

Jonny Betts | Partner | Clear View Healthcare Partners

Kevin McDermott

Kevin McDermott | Strategic Advisor & Thought Partner for Commercialization, Market Access and Program Management | American Biotech Innovation Alliance (ABIA)

Wendy Rockwell

Wendy Rockwell, Doctoral Candidate (DPP) | Executive Director, Strategic Payer Accounts | Summit Therapeutics

Akash Jain

Akash Jain | Director | Merck

Annie Curti

Annie Curti | Director, Product Strategy & Launch Excellence (Hematology) | Novartis

Andrew Majoch

Andrew Majoch | Chief of Staff & Vice President, North American Operations | Immunic Therapeutics

Hema Viswanathan

Hema Viswanathan | Senior Director Health Economics Outcomes Research (HEOR) | BridgeBio

16 Nov
digital twins predictive maintenance panel
  • 12:30 - 13:00
  • Hall 6

Pricing for Innovation Under Pressure: Defending Value

Moderator
Jasvinder Banga

Jasvinder Banga | Associate Director, Commercial Finance | Regeneron

Speakers
Sanket Shah

Sanket Shah, MBBS, PhD | Director, Global Value & HEOR | Jazz Pharmaceuticals

Shah Hussain

Shah Hussain | Senior Director of Access Strategy and Pricing | Amylyx Pharmaceuticals

John Sears

John Sears, PhD, MBA | Senior Director, Hematology Global Commercial Development | CSL

David T. Grace

David Grace | Executive Director, US General Management, Commercial Capabilities Lead (Renal Business Unit) | Novartis Pharmaceuticals

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
manufacturing packaging registration day 2
  • 07:30 - 08:30
  • Hall 6

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
chairman address day 2
  • 08:30 - 08:40
  • Hall 6

Chairman's Address

Vinícius Dantas Alves

Associate Vice President & Global Brand Lead ASMD

Sanofi

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
Phil Tennant
  • 09:00 - 09:15
  • Hall 6

From Approval to Adoption: What It Really Takes to Launch a New Standard of Care Rare Disease Medicine in America

Phil Tennant

Chief Commercial Officer

Precigen: Advancing Medicine with Precision®

17 Nov
shop floor to shelf alignment panel
  • 09:15 - 09:45
  • Hall 6

Navigating Reimbursement Challenges: Strategies to Improve Patient Access

Moderator
Yasmin D

Yasmin D. | Director, Global Marketing Oncology | Merck

Speakers
Jonah Phelps

Jonah Phelps | Area Reimbursement Lead-Southwest | Novartis

Corey Morton

Corey Morton | Field Reimbursement Manager Oncology-Urology | Johnson & Johnson Innovative Medicine

Stephen Meaney

Stephen Meaney | Associate Director, Market Access | LEO Pharma Inc.

17 Nov
digital twins predictive maintenance panel
  • 09:45 - 10:15
  • Hall 6

Affordability vs Innovation: Redefining Value Through Evolving HTA & Pricing Frameworks

Moderator
Ulrich Neumann

Ulrich Neumann | Director of Access & Policy Research, J&J | Johnson & Johnson

Speakers
Sara Yin

Sara (Xiaoyan) Yin | Former Global Strategic Pricing Lead | Boehringer Ingelheim

Sherrita Dorsey

Sherrita Dorsey, MSN FNP RN | US Head Patient and Professional Advocacy | Amicus Therapeutics

Kellie Murphy

Kellie Murphy, MBA | Senior Director, Ryoncil Market Access & Reimbursement | Mesoblast Limited

17 Nov
company pitch manufacturing day2
  • 10:15 - 10:30
  • Hall 6

Company Pitch 1

Presentations by Sponsoring Companies.

10:15 – 10:30
Company Presentation 1
17 Nov
serialization anti counterfeiting track trace panel
  • 11:30 - 12:00
  • Hall 6

Commercial Differentiation in Competitive Markets: Building Value Beyond Clinical Outcomes

Moderator
Hachem Mahfouz

Hachem Mahfouz | Director, Immunoglobulin Franchise & Emerging Therapeutic Areas, CSL Behring | CSL Behring

Speakers
Vinicius Dantas Alves

Vinícius Dantas Alves | Associate Vice President & Global Brand Lead ASMD | Sanofi

Andre Spring

Andre (Berot) Spring | Vice President, Global and U.S. Solid Tumor Oncology Marketing | Regeneron

Yvonne Bryant

Yvonne Bryant | Hemoglobinopathies Commercialization Head | Novo Nordisk

Vijay Iyengar

Vijay Iyengar, MD | Executive Vice President, Global Medical Affairs, Product, & Partnership Strategy | Incyte

Xiao Zhang

Xiao Zhang, PharmD, MBA | Head, Global Commercial Strategy Gastroenterology | AbbVie

Chinmay Pande

Chinmay Pande | Regional Sales Director Portfolio | GSK

17 Nov
sustainable packaging circularity panel
  • 12:00 - 12:30
  • Hall 6

AI & Digital Transformation in Commercial Strategy: Redefining Engagement, Insights & Market Performance

Moderator
Robert Izquierdo

Robert Izquierdo | Lead Global Omnichannel Marketing Strategist & Data Analytics Architect | Gilead Sciences

Speakers
Teddy Sun

Teddy Sun | Global Oncology Business Partner, Medical & Access | Takeda

James Shaw

James Shaw | Associate Director - Marketing Excellence | Takeda Oncology

Boris Velinov

Boris Velinov | Director, Global Marketing & Commercial Strategy | Cytokinetics

Akash Jain

Akash Jain | Director | Merck

17 Nov
company pitch packaging day2
  • 12:30 - 13:00
  • Hall 6

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
Digital Health & Diagnostics registration
  • 07:30 - 08:30
  • Hall 7

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
Chairman's Address - Digital Health
  • 08:30 - 08:40
  • Hall 7

Chairman's Address

Karan Syal, PhD

Director, Commercial AI Acceleration and Innovation

Kite Pharma

16 Nov
Digital Health networking
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
Digital Therapeutics Panel
  • 08:55 - 09:25
  • Hall 7

Real-World Data, Digital Biomarkers & Predictive Health Intelligence

Moderator
Francesco Onorati

Francesco Onorati | Director, Statistics, Quantitative Sciences, DQS, R&D | Takeda

Speakers
Arup Pramanik

Arup Pramanik MD, MSc, MBA | Head of Global RWE and HEOR Strategy, Immunology | UCB

Amy Berk

Amy Berk DNP, MSN, APRN | Frontier Industry Executive, Healthcare; Director, Population Health | Microsoft

Kal Chaudhuri

Kal Chaudhuri, MBA | Patient Adv. Analytics & AI Product Line Owner | Sanofi

Nathan Lear

Nathan Lear | Head (Senior Director), Advanced Analytics Medical Affairs | AstraZeneca

16 Nov
Digital Therapeutics Panel
  • 09:25 - 09:55
  • Hall 7

Generative AI in Biopharma: Productivity Gains Without Compliance Risk

Moderator
Melissa St.Amand

Melissa St.Amand | Global Head of MSAT Digital Transformation | Sanofi

Speakers
Karan Syal

Karan Syal, PhD | Director, Commercial AI Acceleration and Innovation | Kite Pharma

Flora Nanda

Flora Nanda | Head of Data & AI | Legend Biotech

Priyanka Chhikara

Priyanka Chhikara | Head of Global Risk Management, Aggregate Reports and Data Science | CSL

Krishna Avva

Krishna Avva | Director, IT Architecture | Gilead Sciences

Emmanuel Akinlabi

Emmanuel Akinlabi | Associate Director - Data Science | Merck

16 Nov
advanced disease models
  • 09:55 - 10:15
  • Hall 7

Keynote Presentation

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:15 - 10:30
  • Hall 7

Company Pitch 1

Presentations by Sponsoring Companies.

10:15 – 10:30
Company Presentation 1
16 Nov
Companion Diagnostics Panel
  • 11:30 - 12:00
  • Hall 7

AI-Powered Patient Engagement & Personalized Care: Improving Outcomes Through Digital Innovation_Current Perspective

Moderator
Dan Eversole

Daniel (Dan) Eversole, Ph.D. | Patient Health Excellence Lead (Director) | Takeda

Speakers
Lauren Bataille

Lauren Bataille | Head, Digital Health Strategy | Evinova (An AstraZeneca Company)

Sudhir Shandilya

Sudhir Shandilya | Director, AI Product Owner | Corporate Affairs, Legal & Compliance, Partnering & Alliances | Sanofi

Molly Liu

Molly Liu | Associate Director, AI & Data Science | Bristol Myers Squibb

16 Nov
Telehealth IoT Panel
  • 12:00 - 12:30
  • Hall 7

Remote Patient Monitoring & Decentralized Healthcare: The Future of Continuous Care

Moderator
Nikhil Khade

Nikhil Khade | Director, Digital Health, Bristol Myers Squibb | Bristol Myers Squibb

Speakers
Barbara Nollau

Barbara Nollau | Executive Director, Precision Medicine, Diagnostics and R&D Supplier Quality | Amgen

Gizem Demircioglu

Gizem Demircioglu | Director, Digital Health Strategy & Innovation | Evinova (an AstraZeneca Company)

Jimish Mehta

Jimish Mehta, PharmD, MSCE | AI Platform Product Lead | Astellas Pharma

Trupen Modi

Trupen Modi | Sr. Industry Executive, Healthcare | Microsoft

Garrett Manasco

Garrett Manasco | Associate Director, Clinical Artificial Intelligence - Data and Medical Monitoring | AbbVie

16 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 7

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
16 Nov
Food & Beverages
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
Digital Health & Diagnostics registration day 2
  • 07:30 - 08:30
  • Hall 7

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
Chairman's Address Day 2 - Digital Health
  • 08:30 - 08:40
  • Hall 7

Chairman's Address

Vamsi Tammana

Global Head AI Governance, IT GRC and Network Security Operations

Legend Biotech

17 Nov
Digital Health networking day 2
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
Diagnostic Data Ownership Panel
  • 08:55 - 09:25
  • Hall 7

Model Validation and Governance: The New Standard for Trust

Moderator
Caitlin Doyle Weiss

Caitlin Doyle Weiss | Senior Director, Enterprise AI GRC | GSK

Speakers
Vamsi Tammana

Vamsi Tammana | Global Head AI Governance, IT GRC and Network Security Operations | Legend Biotech

Shams Zaman

Shams Zaman, PhD | Head of Enterprise AI | Acadia Pharmaceuticals

Gizem Demircioglu

Gizem Demircioglu | Director, Digital Health Strategy & Innovation | Evinova (an AstraZeneca Company)

Anubhav Srivastava

Anubhav Srivastava | Head of AI Engineering & Generative AI | Novo Nordisk

17 Nov
Diagnostic Data Ownership Panel
  • 09:25 - 09:55
  • Hall 7

Wearables & Smart Health Devices: Enabling the Future of Connected Care

Speakers
Samir Shah

Samir Shah | Director, Devices and Digital Therapeutics, CMC Regulatory Affairs | AstraZeneca

David Morra

David Morra | Head, Enabling Healthcare Technologies | CSL

Samantha Volkens

Samantha Volkens, RN, BSN, MBA | Partnerships Lead, Life Sciences | Digital Medicine Society (DiMe)

17 Nov
advanced disease models
  • 09:55 - 10:15
  • Hall 7

Keynote Presentation

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 10:15 - 10:30
  • Hall 7

Company Pitch 1

Presentations by Sponsoring Companies.

10:15 – 10:30
Company Presentation 1
17 Nov
Companion Diagnostics Panel
  • 11:30 - 12:00
  • Hall 7

AI-Powered Patient Engagement & Personalized Care: Improving Outcomes Through Digital Innovation_Future Perspective

Moderator
Krishna Avva

Krishna Avva | Director, IT Architecture | Gilead Sciences

Speakers
Harsha Agashe

Harsha Agashe | Head of Digital Health Portfolio Analytics | Takeda

Amy Berk

Amy Berk DNP, MSN, APRN | Frontier Industry Executive, Healthcare; Director, Population Health | Microsoft

Arpita Bhowmick

Arpita Bhowmick | Head of Commercial & Patient Service IT, Rare Disease Unit, US | AstraZeneca

17 Nov
Diagnostics Responsibility Panel
  • 12:00 - 12:30
  • Hall 7

AI in Drug Discovery & R&D Transformation

Moderator
Flora Nanda

Flora Nanda | Head of Data & AI | Legend Biotech

Speakers
Sourabh Prakash

Sourabh Prakash | Associate Director, AI Innovation Lab | Bristol Myers Squibb

Arup Pramanik

Arup Pramanik MD, MSc, MBA | Head of Global RWE and HEOR Strategy, Immunology | UCB

Azim Dehghani Amirabad

Azim Dehghani Amirabad | Principal Artificial Intelligence Scientist II | Johnson & Johnson Innovative Medicine

Pankaj Dwivedi

Pankaj Dwivedi | Associate Principal Scientist-Digital Technologies (Insights) | Merck

Jian Zhu

Jian Zhu | Sr. Director, Innovation and Strategy Lead, Quantitative Sciences and Evidence Generation | Astellas Pharma

17 Nov
collaboration biotech pharma Philadelphia U.S conference
  • 12:30 - 13:00
  • Hall 7

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
Food & Beverages Day 2
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
Investment Registration
  • 07:30 - 08:30
  • Hall 4

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
Chairman Address
  • 08:30 - 08:40
  • Hall 4

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
Networking
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 4

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
Company Pitch
  • 12:30 - 13:00
  • Hall 4

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
16 Nov
Food & Beverages
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 4

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 4

Keynote Presentation

17 Nov
Investment Registration Day 2
  • 07:30 - 08:30
  • Hall 4

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
Chairman Address Day 2
  • 08:30 - 08:40
  • Hall 4

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
Networking Day 2
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 4

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
Company Pitch
  • 12:30 - 13:00
  • Hall 4

Company Pitch 2

Presentations by Sponsoring Companies.

12:30 – 12:45
Company Presentation 1
12:45 – 13:00
Company Presentation 2
17 Nov
Food & Beverages Day 2
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 4

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 4

Keynote Presentation

16 Nov
Biologics Registration
  • 07:30 - 08:30
  • Hall 2

Conference Registration

Registration, Badge Collection, Morning Coffee

16 Nov
Chairman Address
  • 08:30 - 08:40
  • Hall 2

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

16 Nov
Networking
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
16 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 2

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
16 Nov
Company Pitch
  • 12:00 - 13:00
  • Hall 2

Company Pitch 2

Presentations by Sponsoring Companies.

12:00 – 12:15
Company Presentation 1
12:15 – 12:30
Company Presentation 2
12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
16 Nov
Food & Beverages
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
16 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 2

Keynote Presentation

16 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 2

Keynote Presentation

17 Nov
Biologics Registration Day 2
  • 07:30 - 08:30
  • Hall 2

Conference Registration

Registration, Badge Collection, Morning Coffee

17 Nov
Chairman Address Day 2
  • 08:30 - 08:40
  • Hall 2

Chairman's Address

Join our Chairman for an insightful opening address that sets the stage for U.S Biotech Day. This session will present current landscape of life sciences dealmaking, exploring why external innovation is more crucial than ever for big pharma.

17 Nov
Networking Day 2
  • 08:00 - 18:00
  • Activity Halls

Calendar of Activities

Discover what’s happening throughout the event:

08:45 – 13:00
Panel Sessions, Keynotes & Showcasing
09:00 – 18:00
Networking & Pre-Arranged Meetings
09:00 – 18:00
Exhibitions & Poster Sessions
17 Nov
Company Pitch
  • 09:45 - 10:30
  • Hall 2

Company Pitch 1

Presentations by Sponsoring Companies.

09:45 – 10:00
Company Presentation 1
10:00 – 10:15
Company Presentation 2
10:15 – 10:30
Company Presentation 3
17 Nov
Company Pitch
  • 12:00 - 13:00
  • Hall 2

Company Pitch 2

Presentations by Sponsoring Companies.

12:00 – 12:15
Company Presentation 1
12:15 – 12:30
Company Presentation 2
12:30 – 12:45
Company Presentation 3
12:45 – 13:00
Company Presentation 4
17 Nov
Food & Beverages Day 2
  • 08:00 - 18:00
  • Main Hall

Food & Beverages

Hot food and cold drinks will be served.

08:00 – 10:00
Morning Coffee
10:30 – 11:30
Coffee Break
13:00 – 14:00
Lunch
15:00 – 17:00
Coffee Break
17 Nov
advanced disease models
  • 14:00 - 14:15
  • Hall 2

Keynote Presentation

17 Nov
advanced disease models
  • 14:15 - 14:30
  • Hall 2

Keynote Presentation